Ballicules.com

Remifentanil

ULTIVA

What it isEsterase-cleared mu-opioid agonist; tightly titratable analgesia during anesthesia.

Why this oneRecovery remains rapid after prolonged infusion and does not depend on hepatic or renal clearance.

What limits it⚑ Analgesia ends abruptly, so longer coverage must precede discontinuation; hyperalgesia, respiratory depression, and chest rigidity can occur.

FDA-approved for

FDA label

BOXED WARNING Addiction, abuse, and misuse; life-threatening respiratory depression; profound sedation/respiratory depression/death with concomitant benzodiazepines or other CNS depressants
FDA dosingPopulationStartTargetMax
Analgesic during induction/maintenance of general anesthesiaAdultsContinuous IV infusion, titrated to effect (see full PI tables)Titrate to effectPer PI
Analgesic component of anesthesiaGeriatric >65 yDecrease starting dose by 50%Titrate to effectPer PI
Analgesic component of anesthesiaPediatricWeight-based (see PI)Titrate to effectPer PI

Renal No specific adjustment; titrate to effect (caution in renal impairment)

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Insufficient human data; prolonged use may cause neonatal opioid withdrawal

Lactation Unknown if excreted in human milk; monitor breastfed infant for sedation/respiratory depression

⚠ BOXED WARNINGS

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Remifentanil ballicule

Remifentanil ballicule: receptor binding, kinetics and half-life diagram

Open Remifentanil in the interactive console ↗

Memory aids: mascots and interaction avatars

Remifentanil ULTIVA mascot mnemonic cartoon
“Ultra-Rimmy fountain eel”
Remifentanil Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Remifentanil in the interactive console ↗